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We thank Professors Evans and Wilkins for their interest in our systematic 
review.1 
 
We have reached the same conclusion as previous systematic reviews published 
in 20082 and 20143 and a review prepared for the New Zealand Ministry for 
Health in 20094. Even the ‘alternative systematic review’ prepared by Professors 
Evans and Allen about which we have significant misgivings  concludes that 
‘larger and rigorous randomised controlled trials of interventions for visual 
stress are required’.5 
 
Professor Wilkins makes a sweeping statement that the Cochrane tools for 
assessing bias are ‘not up to the job’. However, there is ample evidence from 
meta-epidemiological studies that the domains of bias featured in the Cochrane 
tools do influence trial results6,7 and for this reason they have gained 
international acceptance for the purpose of assessing randomised controlled 
trials (RCTs). In fact, inconsistent scoring of bias reflects usually results from 
ambiguous descriptions of trial methodology not the shortcomings of the 
Cochrane tools,  and if trials were reported according to the CONSORT 
statement8, it would be easier to rate them in a consistent manner.  
 
Systematic reviews, in common with all forms of research, have their limitations. 
However, when the results of systematic reviews with meta-analysis are 
followed up with large scale confirmatory RCTs, the positive effects identified by 
reviews comprising multiple small or underpowered studies tend not to be 
replicated.9,10 
 
The fundamental component of a systematic review is the risk of bias (RoB) table 
and the results of this table should inform the discussion.11 Professor Wilkins 
and Evans have left the RoB table used in our review essentially unchallenged. 
For this reason the accusation that we have adopted a light touch to studies with 
negative results compared with those that display positive results is unfounded. 
We would, of course, be happy to review any judgments of bias in the RoB table 
that are felt to be incorrect.  
 
Professor Evans advises that our review should be read alongside their 
‘alternative systematic review’5 in order to obtain ‘a balanced insight’. Their 
review used the Critical Appraisal Skills Program checklist (CASP)12, another 
recognised tool for evaluating bias. However, the domains of bias of the CASP 
checklist are incompletely represented in their RoB table. For this reason we do 
not believe readers should attach equal weight to the two reviews.1,5 We have 
raised our concerns about their application of the CASP tool, as well as other 
concerns about their review, in a letter to the editor of the journal where their 
review was published.13  
 
 
Professor Wilkins raised the issue of lack of detail on the agreement between the 
individuals making the RoB assessments. There was good agreement between us 
in the scoring of the domains of bias. The one area of difference (five studies) 
related to the scoring of allocation concealment. However, this occurred in 
studies using a crossover methodology, which were scored at low risk of bias for 
allocation concealment and random sequence generation irrespective of the 
ambiguities frequently found in the methods sections of the papers we reviewed. 
This is because such studies are usually at low risk of confounding at baseline. It 
could be argued that by adopting this approach we have relatively disadvantaged 
studies such as Ritchie et al.14 which used a rigorous central allocation technique 
for random sequence generation and allocation concealment, but which also 
received a low risk of bias rating in these domains. This is another reason why 
we do not accept the allegation that we have adopted a light touch to studies 
with ‘negative’ results. 
 
The principle source of bias in studies of Intuitive Overlays and Precision Tinted 
Lenses, in which both respondents acknowledge a financial conflict of interest 
that could potentially influence their views, was a lack of masking, because 
coloured overlays were compared with a no overlay or clear overlay condition. It 
is neither  ‘subjective nor untraceable’  to argue that these studies are at higher 
risk of bias in the domain ‘blinding of personnel and participants’ compared to 
studies that compare a chosen colour with a placebo colour. Similarly, a study 
that follows up only 52.7% of participants15 can only be deemed to be at high 
risk of attrition bias. We would challenge any reviewer to score such studies 
differently and most systematic reviews would not even include such studies in 
the final synthesis. Also, as stated above, neither Professors Evans nor Wilkins 
indicated that different judgments of bias would have been more appropriate for 
any of the studies we reviewed.  
 
One potential source of bias in RCTs is the source of funding. Evidence from two 
major systematic reviews has shown that this can influence the result of trial in a 
way that is favourable to the sponsor. 16.17 For this reason, some systematic 
reviews consider the source of funding under the heading ‘other sources of bias. 
We note that in many of the studies of Intuitive overlays and Precision Tinted 
Lenses, the authors make financial disclosures but the source of funding for the 
study is often not made clear. Because we did not consider this in our review, it 
is possible we may even have underestimated the risk of bias of many of the 
studies we included. 
 
Of course, there is no such thing as a perfect trial and for many of the studies that 
we reviewed limited resources were available.  However, numerous participants 
have been enrolled onto time-costly studies comparing coloured overlays with 
the no overlay or clear overlay condition. The same resources, properly 
marshalled, could have financed studies at lower risk of bias. 
 
It is suggested that we have confused the steps required to diagnose visual stress 
and place precedence on an immediate improvement with an overlay, as 
opposed to sustained voluntary use. However, the authors do not consistently 
define how long an individual has to use an overlay to have clinically meaningful 
visual stress. In some studies it could be as little as three weeks15 and in others 
12 weeks or more. 18 Any test that requires a lengthy assessment of all children 
and issuing of overlays to as many as 60% to identify a subgroup who may or 
may not benefit in terms of reading is not an economically viable or ethically 
appropriate process. Professor Evans has himself published a study that used the 
criterion of immediate benefit from overlays19 and has cited such a study 
favourably as evidence that overlays can improve reading.20. It appears that this 
‘confusion’ is not limited to our review. A pre-requisite for more rigorous trials is 
an agreed definition of clinically significant visual stress. Professor Evans 
acknowledges as much when he states that ‘improvements in the diagnosis of 
this condition [visual stress] are also a priority’.4 
 
It is argued that the negative results of placebo controlled studies were a result 
of using naturalistic text which is too large and too widely spaced to demonstrate 
the beneficial effect of coloured filters, this being the motivation for developing 
the Wilkins Rate of Reading Test (WRRT). However, since none of the studies 
utilising the WRRT had a well-designed placebo control condition, the most 
likely explanation for the discrepancy between studies using naturalistic text and 
the WRRT has to be placebo effects. Importantly, we noted that studies utilising 
naturalistic text did show improvements in reading using the chosen filter but in 
contrast to poorly controlled studies this improvement was matched by the 
placebo filter. Furthermore, unless it can be shown that overlays or lenses 
produce benefits for reading the sort of text that is encountered in everyday life, 
the clinical or educational relevance of improvements observed with the WRRT 
remains questionable. In the case of children who are still undergoing reading 
development, one should also expect to see significantly larger gains in test 
scores on standardised tests of reading following longer-term use of overlays 
than compared to a control group. Our literature search identified no RCTs with 
sufficiently prolonged follow-up to answer this question. 
 
We appreciate the desire to isolate visual factors that could be interfering with 
reading; however, it is not yet clear if the WRRT achieves this aim. The extent to 
which performance on this test is influenced by higher order language skills 
and/or reading experience, remains to be examined. Furthermore, unless it can 
be shown that increases in reading speed (on the WRRT) are accompanied by 
preserved (or better) comprehension then improvements in reading may be due 
to the reader becoming more confident and less risk averse. We acknowledge 
that reading accuracy is also measured in the WRRT but it is not clear if this is a 
sufficient measure of response-criterion. For example, a recent review found that 
speed reading apps improve reading speed at the expense of comprehension.21  
 
We are criticised for scoring Henderson et al. 22 and Ritchie et al.14 as being at 
uncertain risk of external bias even though they utilised the WRRT. However, 
both of these studies also used naturalistic text.  
 
According to Professor Wilkins we make sweeping generalisations which the 
reader is obliged to take on trust. For example, that ‘improvements have been 
reported with prescribed overlays and lenses but similar improvements are 
found with placebo colours’. In fact, the references to support this assertion are 
provided in the general discussion (page 537 paragraph 4). 
 
With regard to our ignoring individual participants who showed substantial 
improvements in reading, it is important to remember that post-hoc subgroup 
analyses are hypothesis generating only and have been compared with a 
marksman firing shots at a barn and painting a target around the bullet hole 
after the event.23 The target only shows how accurate the shot was if it was in 
place before the shooting. For this reason, post-hoc subgroup analysis would not 
normally play any part in a systematic review and studies that contain such 
analyses would be scored at high risk of reporting bias. We agree, however, that 
the authors of those studies could usefully have looked at the subgroups who 
appeared to benefit to see how they differed from their peers who obtained no 
benefit. Such an analysis might have generated useful hypotheses that could have 
been tested in confirmatory trials, which might in turn have been included in a 
systematic review. We did attempt to further analyse the RCT published in 1994 
by Wilkins et al.15 We requested further data concerning the subgroup of 36 
participants (out of 68) who completed symptom diaries to determine whether 
equipoise had been lost with regard to subjects using their chosen lens or 
placebo lens first. Unfortunately these data were not available.  
 
Professor Evans adopts the logic that because the majority of studies show a 
positive effect of coloured filters this is evidence for their effectiveness. However, 
small studies at high risk of bias are cheaper and easier to perform for which 
reason they generally outnumber larger more rigorous studies. Consequently, 
simple counting of studies without reference to RoB will overestimate treatment 
effects. This so called ‘vote-counting’ approach might have some value if the 
positive studies were at high risk of bias in different bias domains. However 
because the studies showing positive results are all at high risk of bias in the 
same domain - lack of masking – the value of the approach of simply counting the 
number of studies with positive results is extremely limited.  The ‘vote-counting’ 
approach to systematic reviews has been heavily criticised11 and is not 
advocated by the Cochrane Collaboration.24 
 
Scepticism is a condition of doubt or uncertainty about putative knowledge that 
is usually seen as a virtue; particularly so in scientific circles. If high quality trials 
support the use of coloured overlays and/or lenses then of course we would be 
happy to see them having positive effects. Equally, Professors Evans and Wilkins 
should acknowledge the possibility that the larger and more rigorous RCTs, that 
we all agree are necessary, may not support their beliefs. It is unfortunate, for all, 
that overlays and lenses have been marketed prematurely, before robust 
evidence has been obtained.  
 
There is near universal agreement that properly designed RCTs are required and 
research ethics committees should carefully consider whether or not to give 
approval to further studies at high risk of bias due to the lack of a proper placebo 
control condition, including adequate masking of study personnel. As we outline 
in our article, future confirmatory trials should pre-register their methodology, 
sample size and proposed statistical tests and ‘real world’ outcome measures 
should be incorporated. The results should be reported in accordance with 
current standards for reporting trials.8  
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